EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults

Rowan Saloner iD, Lawren VandeVrede, Breton M Asken, Emily W Paolillo, Eva Q Gontrum, Amy Wolf, Argentina Lario-Lago, Marta Milà-Alomà, Gallen Triana-Baltzer, Hartmuth C Kolb, Dena B Dubal, Gil D Rabinovici und 4 weitere

Alzheimer's & Dementia · 2024-01 · 20 (1) · 376-387

DOI: 10.1002/alz.13454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 28.08.2023. Verfasst von Rowan Saloner und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Accumulating evidence indicates disproportionate tau burden and tau‐related clinical progression in females. However, sex differences in plasma phosphorylated tau (p‐tau)217 prediction of subclinical cognitive and brain changes are unknown. METHODS We measured baseline plasma p‐tau217, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) in 163 participants (85 cognitively unimpaired [CU], 78 mild cognitive impairment [MCI]). In CU, linear mixed effects models examined sex differences in plasma biomarker prediction of longitudinal domain‐specific cognitive decline and brain atrophy. Cognitive models were repeated in MCI. RESULTS In CU females, baseline plasma p‐tau217 predicted verbal memory and medial temporal lobe trajectories such that trajectories significantly declined once p‐tau217 concentrations surpassed 0.053 pg/ml, a threshold that corresponded to early levels of cortical amyloid aggregation in secondary amyloid positron emission tomography analyses. CU males exhibited similar rates of cognitive decline and brain atrophy, but these trajectories were not dependent on plasma p‐tau217. Plasma GFAP and NfL exhibited similar female‐specific prediction of medial temporal lobe atrophy in CU. Plasma p‐tau217 exhibited comparable prediction of cognitive decline across sex in MCI. DISCUSSION Plasma p‐tau217 may capture earlier Alzheimer's disease (AD)‐related cognitive and brain atrophy hallmarks in females compared to males, possibly reflective of increased susceptibility to AD pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionAdultHumansFemaleMaletau ProteinsBrainPositron-Emission TomographyAtrophyBiomarkersAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid positron emission tomographycognitioncognitively unimpairedglial fibrillary acidic proteinmedial temporal lobeneurofilament lightphosphorylated tau217plasma biomarkerssex differencesverbal memory

Substanzen

tau ProteinsBiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
  • Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA.
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
  • Neuroscience Biomarkers, Janssen Research & Development, LLC, San Diego, California, USA.

ORCID-Profile: Rowan Saloner

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Alzheimer's Association
  • Larry L. Hillblom Foundation

Zitieren

APA

Saloner, R., VandeVrede, L., Asken, B. M., Paolillo, E. W., Gontrum, E. Q., Wolf, A., Lario-Lago, A., Milà-Alomà, M., Triana-Baltzer, G., Kolb, H. C., Dubal, D. B., Rabinovici, G. D., Miller, B. L., Boxer, A. L., Casaletto, K. B., & Kramer, J. H. (2024). Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimer's & Dementia, 20(1), 376-387. https://doi.org/10.1002/alz.13454

Vancouver

Saloner R, VandeVrede L, Asken BM, Paolillo EW, Gontrum EQ, Wolf A, et al. Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimer's & Dementia. 2024;20(1):376-387. doi:10.1002/alz.13454

BibTeX
@article{Saloner2024,
  author = {Saloner, Rowan and VandeVrede, Lawren and Asken, Breton M and Paolillo, Emily W and Gontrum, Eva Q and Wolf, Amy and Lario-Lago, Argentina and Milà-Alomà, Marta and Triana-Baltzer, Gallen and Kolb, Hartmuth C and Dubal, Dena B and Rabinovici, Gil D and Miller, Bruce L and Boxer, Adam L and Casaletto, Kaitlin B and Kramer, Joel H},
  title = {Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {1},
  pages = {376--387},
  doi = {10.1002/alz.13454}
}
Kostenlos starten →